These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 28121474)
1. Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder. Ebrahimi G; Asadikaram G; Akbari H; Nematollahi MH; Abolhassani M; Shahabinejad G; Khodadadnejad L; Hashemi M Am J Drug Alcohol Abuse; 2018; 44(2):193-199. PubMed ID: 28121474 [TBL] [Abstract][Full Text] [Related]
2. Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter. Sandoval-Sierra JV; Salgado García FI; Brooks JH; Derefinko KJ; Mozhui K Clin Epigenetics; 2020 Jun; 12(1):76. PubMed ID: 32493461 [TBL] [Abstract][Full Text] [Related]
3. Opioid Exposure is Associated with Aberrant DNA Methylation of OPRM1 Promoter Region in a Chinese Han Population. Xu J; Wang T; Su Z; Zhou X; Xiang Y; He L; Li C; Yang Z; Zhao X Biochem Genet; 2018 Oct; 56(5):451-458. PubMed ID: 29564682 [TBL] [Abstract][Full Text] [Related]
4. Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts. Chorbov VM; Todorov AA; Lynskey MT; Cicero TJ J Opioid Manag; 2011; 7(4):258-64. PubMed ID: 21957825 [TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence. Zhang H; Herman AI; Kranzler HR; Anton RF; Simen AA; Gelernter J J Hum Genet; 2012 Oct; 57(10):670-5. PubMed ID: 22914673 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic variation in OPRM1 gene in opioid-exposed mother-infant dyads. Wachman EM; Hayes MJ; Shrestha H; Nikita FNU; Nolin A; Hoyo L; Daigle K; Jones HE; Nielsen DA Genes Brain Behav; 2018 Sep; 17(7):e12476. PubMed ID: 29575474 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic and sex differences in opioid use disorder in chronic pain: A real-world study linked with OPRM1 DNA methylation. Agulló L; Escorial M; Orutño S; Muriel J; Sandoval J; Margarit C; Peiró AM Addict Biol; 2024 Jul; 29(7):e13422. PubMed ID: 38949208 [TBL] [Abstract][Full Text] [Related]
8. OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients. Viet CT; Dang D; Aouizerat BE; Miaskowski C; Ye Y; Viet DT; Ono K; Schmidt BL J Pain; 2017 Sep; 18(9):1046-1059. PubMed ID: 28456745 [TBL] [Abstract][Full Text] [Related]
9. Pharmacoepigenetics of the role of DNA methylation in μ-opioid receptor expression in different human brain regions. Knothe C; Oertel BG; Ultsch A; Kettner M; Schmidt PH; Wunder C; Toennes SW; Geisslinger G; Lötsch J Epigenomics; 2016 Dec; 8(12):1583-1599. PubMed ID: 27685027 [TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the Liu L; Yang X; Zhao F; Gao C; Zhang N; Bao J; Li K; Zhang X; Lu X; Ruan Y; Zhong S Am J Drug Alcohol Abuse; 2021 Nov; 47(6):694-703. PubMed ID: 34582308 [TBL] [Abstract][Full Text] [Related]
11. Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease. Xu C; Liu G; Ji H; Chen W; Dai D; Chen Z; Zhou D; Xu L; Hu H; Cui W; Chang L; Zha Q; Li L; Duan S; Wang Q Mol Med Rep; 2018 Nov; 18(5):4297-4302. PubMed ID: 30152845 [TBL] [Abstract][Full Text] [Related]
12. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians. Daher M; Costa FM; Neves FA Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975 [TBL] [Abstract][Full Text] [Related]
13. Association of OPRK1 and OPRM1 methylation with mild cognitive impairment in Xinjiang Han and Uygur populations. Liu G; Ji H; Liu J; Xu C; Chang L; Cui W; Ye C; Hu H; Chen Y; Zhou X; Duan S; Wang Q Neurosci Lett; 2017 Jan; 636():170-176. PubMed ID: 27838450 [TBL] [Abstract][Full Text] [Related]
14. Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain. Doehring A; Oertel BG; Sittl R; Lötsch J Pain; 2013 Jan; 154(1):15-23. PubMed ID: 23273101 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. Wachman EM; Hayes MJ; Lester BM; Terrin N; Brown MS; Nielsen DA; Davis JM J Pediatr; 2014 Sep; 165(3):472-8. PubMed ID: 24996986 [TBL] [Abstract][Full Text] [Related]
17. Association between methylation in the promoter region of the GAD2 gene and opioid use disorder. Tang H; Zhang Y; Xun Y; Yu J; Lu Y; Zhang R; Dang W; Zhu F; Zhang J Brain Res; 2023 Aug; 1812():148407. PubMed ID: 37182687 [TBL] [Abstract][Full Text] [Related]
18. Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population. Albonaim A; Fazel H; Sharafshah A; Omarmeli V; Rezaei S; Ajamian F; Keshavarz P J Addict Dis; 2017; 36(4):227-235. PubMed ID: 28786760 [TBL] [Abstract][Full Text] [Related]
19. A study on methylation of two CpG islands of MAOA gene promoter among opium-addicted males undergoing methadone treatment. Omarmeli V; Sharafshah A; Albonaim A; Keshavarz P Nucleosides Nucleotides Nucleic Acids; 2022; 41(9):841-850. PubMed ID: 35759647 [TBL] [Abstract][Full Text] [Related]
20. Methylation and expression quantitative trait loci rs1799971 in the OPRM1 gene and rs4654327 in the OPRD1 gene are associated with opioid use disorder. Yu J; Zhang Y; Xun Y; Tang H; Fu X; Zhang R; Zhu F; Zhang J Neurosci Lett; 2023 Sep; 814():137468. PubMed ID: 37660978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]